Suppose a researcher in Boston has a promising idea: a particular protein in the amygdala might mark individuals vulnerable to opioid addiction. Testing it the traditional way means years of work before the first measurement, breeding animals, running months of behavioral experiments, collecting tissue. The idea might die simply because testing it costs too much.
Now suppose there is a freezer in San Diego holding brain tissue from hundreds of rats, each one already behaviorally characterized for addiction-like behavior, each one whole-genome sequenced, and the researcher can simply request the samples. The experiment starts in weeks, not years.
That is a biobank: a curated repository of biological samples, systematically collected, annotated, and shared.
What makes the Addiction Biobank different
Many biobanks store samples. What makes an addiction biobank scientifically powerful is the annotation attached to every vial (Carrette et al., 2021):
- Behavior. Every donor animal went through standardized extended-access self-administration of cocaine, oxycodone, or alcohol, and is scored on an Addiction Index, a composite of escalation, motivation, and continued use despite negative consequences. Every sample is labeled with where its donor fell on the continuum from resilient to compulsive.
- Genetics. Every donor is a heterogeneous stock rat with its whole genome sequenced, so any molecular finding can be connected to genetic variation.
- Breadth of tissues. The bank stores not just brain but blood, liver, kidney, heart, spleen, gut, gonads, urine, and feces, preserved by methods compatible with genomic, transcriptomic, proteomic, metabolomic, and anatomical analyses.
A sample without context is a piece of frozen tissue. A sample linked to teh individual’s genome and behavioral history is a data point in every future experiment anyone runs with the collection.
Why sharing multiplies science
The biobank model changes the economics of addiction research:
- A hypothesis can be tested for the cost of an assay, not the cost of a colony, lowering the barrier for new investigators and new ideas (our pilot funding program lowers it further).
- Findings accumulate on common ground. When many labs measure different molecules in the same well-characterized animals, results can be integrated instead of merely compared.
- Animal use is minimized. Each animal’s donation supports many studies across many laboratories, a direct application of the 3Rs (replacement, reduction, refinement).
Using it
The Addiction Biobank operates as a national resource within our center. Investigators anywhere can browse what is available and request samples, including selecting donors by behavioral phenotype (for example, the top and bottom of the Addiction Index distribution) and pairing samples with genotype data. See the Addiction Biobank Core for the request forms, or contact us to discuss a collaboration.
References
- Carrette LLG et al. (2021). The Cocaine and Oxycodone Biobanks, two repositories from genetically diverse and behaviorally characterized rats for the study of addiction. eNeuro 8(3):ENEURO.0033-21.2021. PMID 33875455